Ondansetron Ab

Ondansetron, the active ingredient in Ondansetron Ab, is a 5-HT3 receptor antagonist presented as a strength/form for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is a selective serotonin 5‑HT3 receptor antagonist used in the management of nausea and vomiting across several clinical pathways. - Chemotherapy‑induced nausea and vomiting (CINV): helps control acute and delayed episodes. - Radiation‑induced nausea and vomiting (RINV): reduces the frequency and severity of symptoms. - Post‑operative nausea and vomiting (PONV): decreases incidence after general anesthesia. - Hyper‑emesis gravidarum: provides symptomatic relief when other therapies are insufficient.

Adverse reactions to ondansetron are generally mild to moderate, but clinicians monitor both common and rare events.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel habit changes. - Diarrhoea: transient episodes. - Fatigue: general tiredness. - Dizziness: brief sensations of light‑headedness.

Serious or Rare Side Effects: - QT interval prolongation: may predispose to cardiac arrhythmias. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Serotonin syndrome: rare when combined with other serotonergic agents. - Hepatic enzyme elevation: abnormal liver function tests. - Vision changes: blurred vision or visual disturbances.

When prescribing ondansetron, clinicians consider several safety factors to minimise risk. - Cardiac monitoring: assess baseline ECG in patients with known QT prolongation risk. - Electrolyte balance: correct hypokalaemia, hypomagnesemia, or hypocalcaemia before use. - Drug interactions: review concomitant medications that may affect cardiac rhythm. - Pregnancy: use only if the potential benefit outweighs risk; data are limited. - Lactation: assess infant exposure risk before breastfeeding. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Ondansetron may interact with several drug classes, requiring vigilance from prescribers.

Major Interactions (Avoid): - Anti‑arrhythmic agents (e.g., amiodarone, quinidine): increase risk of QT prolongation. - Certain antipsychotics (pharmacologic ).

Moderate Interaction ( ").

- ").

- "). - "). - "). - ". - "